Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation

Journal of Thoracic Oncology

Volumn 13, Issue 7, 2018, Pages 946-957

  Flores, Raja ^a,e   Taioli, Emanuela ^a,e   Yankelevitz, David F ^a,e   Becker, Betsy J ^b   Jirapatnakul, Artit ^a,e   Reeves, Anthony ^c,e   Schwartz, Rebecca ^a,d,e   Yip, Rowena ^a,e   Fevrier, Esther ^a,e   Tam, Kathleen ^a,e   Steiger, Benjamin ^a,e   Henschke, Claudia I ^a,e   Kaufman, Andrew ^e   Lee, Dong Seok ^e   Nicastri, Daniel ^e   Wolf, Andrea ^e   Rosenzweig, Kenneth ^e   Gomez, Jorge ^e   Beasley, Mary Beth ^e   Zakowski, Maureen ^e   Chung, Michael ^e   Futamura, Rita ^e   Kantor, Sydney ^e   Wallace, Carly ^e   Bhora, Faiz ^e   Raad, Wissam ^e   Evans, Andrew ^e   Choi, Walter ^e   Buyuk, Zrzu ^e   Friedman, Adie ^e   Dreifuss, Ronald ^e   Verzosa, Stacey ^e   Yakubox, Mariya ^e   Aloferdova, Karina ^e   Stacey, Patricia ^e   De Nobrega, Simone ^e   Hakami, Ardeshir ^e   Pass, Harvey ^e   Crawford, Berne ^e   Donnington, Jessica ^e   Cooper, Benjamin ^e   Moreirea, Andre ^e   Sorensen, Audrey ^e   Kohman, Leslie ^e   Dunton, Robert ^e   Wallen, Jason ^e   Curtiss, Christopher ^e   Scalzetti, Ernest ^e   Ellinwood, Linda ^e   Aye, Ralph ^e   Vallieres, Eric ^e   Louie, Brian ^e   Frivar, Alex ^e   Mehta, Vivek ^e   Manning, Kristin ^e   Chona, Maria ^e   Smith, Andrew ^e   Connery, Clifford P ^e   Torres, Emilo ^e   Cruzer, Dan ^e   Gendron, Bruce ^e   Alyea, Sonya ^e   Lackaye, Daniel ^e   Studer, Lauren ^e   Becker, Betsy ^e   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

^c School of Operations Research and Industrial Engineering   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^e NONE

Author keywords

mediastinal lymph nodes; radiotherapy; stage I treatment; surgery

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CANCER; ETHNIC DIFFERENCE; FEASIBILITY STUDY; FEMALE; HUMAN; LOBECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; STUDY DESIGN; SURGICAL MARGIN; SURVIVAL RATE; THORACOTOMY; TREATMENT OUTCOME; TREATMENT PLANNING; VIDEO ASSISTED THORACOSCOPIC SURGERY; FOLLOW UP; HEALTH CARE PLANNING; LUNG RESECTION; LUNG TUMOR; METHODOLOGY; PATHOLOGY; PROCEDURES; RADIOSURGERY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH PLAN IMPLEMENTATION; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; PNEUMONECTOMY; PROSPECTIVE STUDIES; RADIOSURGERY; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 85046360023     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2018.03.009     Document Type: Article

References (56)

1. Moyer, V.A., U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
2. Devita, V.T., Lawrence, T.S., Rosenberg, S.A., (eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology, 10th ed., 2014, Lippincott Williams & Wilkins, Philadelphia, PA.
3. Ginsberg, R., Rubinstein, L., Randomized trial of lobectomy versus limited resection for T1 N0 non–small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995), 615–622 Discussion 622–623.
4. McKenna, R.J., Houck, W., Fuller, C., Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 81 (2006), 421–426.
5. Flores, R., Park, B., Dycoco, J., et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 138 (2009), 11–18.
6. Agzarian, J., Fahim, C., Shargall, Y., Yasufuku, K., Waddell, T.K., Hanna, W.C., The use of robotic-assisted thoracic surgery for lung resection: a comprehensive systematic review. Semin Thorac Cardiovasc Surg 28 (2016), 182–192.
7. Henschke, C., Miettinen, O., Yankelevitz, D., Libby, D., Smith, J., Radiographic screening for cancer. Proposed paradigm for requisite research. Clin Imaging 18 (1994), 16–20.
8. Henschke, C., McCauley, D., Yankelevitz, D., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354 (1999), 99–105.
9. International Early Lung Cancer Action Program I, Henschke, C.I., Yankelevitz, D.F., Libby, D.M., Pasmantier, M.W., Smith, J.P., Miettinen, O.S., Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006), 1763–1771.
10. CALGB 140503: A phase III randomized trial of lobectomy versus sublobar resection for small (≤2cm) peripheral non-small cell lung cancer (NCT00499330). http://www.cancer.gov/about-cancer/treatment/clinical-trials/search/view?cdrid=555324. Accessed March 21, 2018.
11. Chang, J.Y., Senan, S., Paul, M.A., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16 (2015), 630–637.
12. Yankelevitz, D.F., Yip, R., Smith, J.P., et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 277 (2015), 555–564.
13. Yip, R., Yankelevitz, D.F., Hu, M., et al. Lung cancer deaths in the National Lung Screening Trial attributed to nonsolid nodules. Radiology 281 (2016), 589–596.
14. Yip, R., Wolf, A., Tam, K., et al. Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer 97 (2016), 35–42.
15. Henschke, C.I., Yip, R., Smith, J.P., et al. CT screening for lung cancer: part-solid nodules in baseline and annual repeat rounds. AJR Am J Roentgenol 207 (2016), 1176–1184.
16. Yip, R., Yankelevitz, D., Li, K., Xu, D., Jirapatnakul, A., Henschke, C., Lung cancer deaths in the National Lung Screening Trial attributed to cancers manifesting as part-solid nodules. AJR Am J Roentgenol, 2016, 10.2214/ajr.16.16930.
17. Yip, R., Li, K., Liu, L., et al. Controversies on lung cancers manifesting as part-solid nodules. Eur Radiol 28 (2018), 747–759.
18. Flores, R., Bauer, T., Aye, R., et al. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer. J Thorac Cardiovasc Surg 147 (2014), 1619–1626.
19. Altorki, N., Yip, R., Hanaoka, T., et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 147 (2014), 754–762 Discussion 762–764.
20. Flores, R.M., Nicastri, D., Bauer, T., et al. Computed tomography screening for lung cancer: mediastinal lymph node resection in stage IA nonsmall cell lung cancer manifesting as subsolid and solid nodules. Ann Surg 265 (2017), 1025–1033.
21. Engelhardt KE, Feinglass JM, DeCamp MM, Bilimoria KY, Odell DD. Declining Use of Surgical Therapy for Early Stage Non-small Cell Lung Cancer in the United States. Presented at: American Association for Thoracic Surgery Annual Meeting. April 29–May 3, 2017; Boston, MA.
22. Olsen, L., Aisner, D., McGinnis, J., (eds.) The Learning Healthcare System: Workshop Summary of the Institute of Medicine Roundtable on Evidence-Based Medicine, 2007, National Academy Press, Washington, DC, 4–10.
23. National Cancer Institute (U.S.), Lung Cancer Progression Review Group. Report of the Lung Cancer Progress Review Group. http://planning.cancer.gov/library/2001lung.pdf. Accessed March 21, 2018.
24. Concato, J., Shah, N., Horwitz, R., Randomized, controlled trials, observational studies, and the hierarchy of research design. N Engl J Med 342 (2000), 1887–1892.
25. Benson, K., Hartz, A., A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000), 1878–1886.
26. Visvanathan, K., Levit, L.A., Raghavan, D., et al. Untapped potential of observational research to inform clinical decision making: American Society of Clinical Oncology research statement. J Clin Oncol 35 (2017), 1845–1854.
27. Taioli, E., Yip, R., Olkin, I., et al. Survival after sublobar resection for early-stage lung cancer: methodological obstacles in comparing the efficacy to lobectomy. J Thorac Oncol 11 (2016), 400–406.
28. International Early Lung Cancer Action Program Investigators. Program and Consensus statements. International Conferences on Screening for Lung Cancer. http://events.ielcap.org/conferences/past. Accessed March 21, 2018.
29. Aberle, D., Adams, A., Berg, C., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
30. International Early Lung Cancer Action Program Investigators. International Early Lung Cancer Action Program protocol. www.IELCAP.org/protocols. Accessed January 3, 2018.
31. Detterbeck, F.C., Boffa, D.J., Kim, A.W., Tanoue, L.T., The Eighth Edition Lung Cancer Stage Classification. Chest 151 (2017), 193–203.
32. D'Agostino, R.B. Sr., Massaro, J.M., Sullivan, L.M., Non-inferiority trials: design concepts and issues — the encounters of academic consultants in statistics. Stat Med 22 (2003), 169–186.
33. Flight, L., Julious, S.A., Practical guide to sample size calculations: non-inferiority and equivalence trials. Pharm Stat 15 (2016), 80–89.
34. Rassen, J.A., Shelat, A.A., Franklin, J.M., Glynn, R.J., Solomon, D.H., Schneeweiss, S., Matching by propensity score in cohort studies with three treatment groups. Epidemiology 24 (2013), 401–409.
35. Boef, A.G., le Cessie, S., Dekkers, O.M., et al. Physician's Prescribing preference as an instrumental variable: exploring assumptions using survey data. Epidemiology 27 (2016), 276–283.
36. Liu, S., Xie, Y., Jirapatnakul, A., Reeves, A.P., Pulmonary nodule classification in lung cancer screening with three-dimensional convolutional neural networks. J Med Imaging (Bellingham), 4, 2017, 041308.
37. Wolf, A.S., Swanson, S.J., Yip, R., et al. The impact of margins on outcomes after wedge resection for stage I non-small cell lung cancer. Ann Thorac Surg 104 (2017), 1171–1178.
38. Buckstein, M., Yip, R., Yankelevitz, D., Henschke, C., Rosenzweig, K., International Early Lung Cancer Action Program Investigators. Radiation therapy for stage I lung cancer detected on computed tomography screening: results from the international early lung cancer action program. J Radiat Oncol 3 (2014), 153–157.
39. Vazquez, M., Carter, D., Brambilla, E., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 64 (2009), 148–154.
40. Yip R, Taioli E, Schwartz R, et al. A Review of Quality of Life Measures Used in Lung Cancer Surgical Outcomes. 17th IASLC World Conference on Lung Cancer. December 5, 2016; Vienna, Austria.
41. Schwartz, R.M., Yip, R., Flores, R.M., et al. The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical patients. J Surg Oncol 115 (2017), 173–180.
42. Schwartz, R.M., Yip, R., Olkin, I., et al. Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life. J Community Support Oncol 14 (2016), 37–44.
43. Schwartz R. Understanding surgical decision making in early stage lung cancer: Results of a focus group conducted with thoracic surgeons. Oral presentation at the Innovative Statistical Methodology for Assessment of New Techniques in Lung Cancer Diagnosis and Treatment: Workshop I. 2016; New York, NY.
44. Schwartz R, Taioli E, Taylor T, Flores R, Yankelevitz D, Ross S, and Henschke C. Analysis of a focus group discussion with early stage lung cancer survivors on their perception of the surgical decision-making process. Abstract at the 52nd Annual Meeting of the Society of Thoracic Surgery, Poster presentation. Phoenix, AZ January, 2016.
45. Schwartz, R.M., Gorbenko, K., Kerath, S.M., et al. Thoracic surgeon and patient focus groups on decision-making in early-stage lung cancer surgery. Future Oncol 14 (2018), 151–163.
46. Chapple, A., Ziebland, S., McPherson, A., Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ, 328, 2004, 1470.
47. Park, S., Kang, C.H., Hwang, Y., et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancerdagger. Eur J Cardiothorac Surg 49 (2016), e16–e21.
48. Kroenke, K., Spitzer, R.L., Williams, J.B., Lowe, B., An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 50 (2009), 613–621.
49. Sherbourne C, Stewart A. The MOS Social Support Survey. https://www.rand.org/pubs/reprints/RP218.html. Accessed March 21, 2018.
50. Banik, A., Luszczynska, A., Pawlowska, I., Cieslak, R., Knoll, N., Scholz, U., Enabling, Not Cultivating: Received Social Support and Self-Efficacy Explain Quality of Life After Lung Cancer Surgery. Ann Behav Med 51 (2017), 1–12.
51. Flores R, Hensche C, Taioli E, Yankelevitz D. Initiative for Early Lung Cancer Research on Treatment (IELCART). 17th IASLC World Conference on Lung Cancer. December 5, 2016; Vienna, Austria.
52. Henschke, C.I., Salvatore, M., Cham, M., et al. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening. Eur Radiol 28 (2018), 1085–1094.
53. VA Office of Research and Development, Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy (VALOR), In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [2017 Feb 6]. http://clinicaltrials.gov/show/NCT02984761 NLM Identifier: NCT02984761. Accessed March 21, 2018.
54. Chen, X., Li, K., Yip, R., et al. Hepatic steatosis in participants in a program of low-dose CT screening for lung cancer. Eur J Radiol 94 (2017), 174–179.
55. Altorki, N., Lane, M., Bauer, T., et al. Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. J Clin Oncol 28 (2010), 3131–3137.
56. Merad M. Lung cancer immunology. IELCART Meeting. March 18, 2016; New York, NY.